Hedge Fund - Prosight Capital
Albireo Pharma Inc ()
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $ |
2 | 2022 - Q4 (2022-12-31) | $10,518,149 | 5.73% | 486,726 | $ |
3 | 2022 - Q3 (2022-09-30) | $9,510,000 | 5.09% | 491,244 | $ |
4 | 2022 - Q2 (2022-06-30) | $9,290,000 | 7.32% | 467,795 | $ |
5 | 2022 - Q1 (2022-03-31) | $14,318,000 | 9.24% | 480,000 | $ |
6 | 2021 - Q4 (2021-12-31) | $11,973,000 | 7.16% | 514,082 | $ |
7 | 2021 - Q3 (2021-09-30) | $13,885,000 | 7.63% | 445,020 | $ |
8 | 2021 - Q2 (2021-06-30) | $10,381,000 | 6.49% | 295,080 | $ |
9 | 2021 - Q1 (2021-03-31) | $6,005,000 | 4.91% | 170,352 | $ |
10 | 2020 - Q4 (2020-12-31) | $6,556,000 | 3.02% | 174,791 | $ |
11 | 2020 - Q3 (2020-09-30) | $4,088,000 | 1.94% | 122,500 | $ |
12 | 2020 - Q2 (2020-06-30) | $5,266,000 | 2.26% | 198,800 | $ |
13 | 2020 - Q1 (2020-03-31) | $5,409,000 | 2.52% | 330,407 | $ |
14 | 2019 - Q4 (2019-12-31) | $6,283,000 | 2.75% | 247,178 | $ |
15 | 2019 - Q3 (2019-09-30) | $5,050,000 | 2.8% | 252,500 | $ |
16 | 2019 - Q2 (2019-06-30) | $8,167,000 | 4.11% | 253,327 | $ |
17 | 2019 - Q1 (2019-03-31) | $8,691,000 | 3.8% | 269,836 | $ |
18 | 2018 - Q4 (2018-12-31) | $6,627,000 | 3.42% | 270,146 | $ |
19 | 2018 - Q3 (2018-09-30) | $5,369,000 | 2.99% | 162,905 | $ |
The displayed share prices are average quarterly stock market prices.